Advertisement

Picture biomindz Mainz Biomed LSE Colorectal Cancer Screening 650x100px
Organisation › Details

Kranus Health (Group)

Kranus Health is the leading global provider of integrated digital care in urology. Current flagship products include Kranus Edera, a novel treatment for erectile dysfunction and Kranus Lutera, a treatment for prostate enlargement. With Kranus Edera, the company has introduced the first digital health application (DiGA) as a fully reimbursable prescription app for the treatment of erectile problems and their causes. One of the largest studies in the urology sector, conducted at the University Hospital Münster, has substantiated the effectiveness of this therapeutic approach confirming that Kranus Edera presents a scientifically proven alternative and complement to Viagra and similar medications. Kranus Health was founded in 2020 under the scientific leadership of Prof. Dr. Kurt Miller, former Medical Director of the Department of Urology at Charité. Co-founders and Co-CEOs Jens Nörtershäuser & Thilo Kleinschmidt, who have known each other for many years through their shared time at McKinsey, lead the venture. Nikolay Dimolarov (formerly Celonis) complements the four-member founding team as Chief Technology Officer. Kranus Health's international team now comprises over 70 employees working at the company's locations in Munich, Berlin and Paris. Together with an experienced leadership team, the company envisions developing further digital therapies and expanding its global presence to enhance healthcare in urology worldwide. *

 

Period Start 2020-08-04 established
Products Industry digital health (healthcare informatics)
  Industry 2 Kranus Edera prescription digital therapeutic
Persons Person Nörtershauser, Jens (Kranus Health 202206 Co-CEO + Co-Founder)
  Person 2 Kleinschmidt, Thilo (Kranus Health 202206 Co-CEO + Co-Founder)
     
Region Region München (Munich)
  Country Germany
  Street 10 Westenriederstr.
  City 80331 München
  Tel +49-89-124146-79
    Address record changed: 2022-06-21
     
Basic data Employees B: 11 to 50 (2022-06-20)
     
    * Document for »About Section«: Kranus Health GmbH. (10/2/23). "Press Release: Kranus Health Now Raised a Total of USD 15 Million Series A Funding to Realize Its Vision of Integrated Care in Urology". Berlin, Munich & Paris.
     
   
Record changed: 2024-04-04

Advertisement

Picture biomindz TRON LSE Mainz Translation Cancer Immunotherapy 650x200px

More documents for Kranus Health (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture biomindz TRON LSE Mainz Translation Cancer Immunotherapy 650x300px




» top